Company Search:
Advanced Search
Sponsored Links
Wilson Therapeutics Company Snapshot
Wilson Therapeutics operates within the Biological products exc. diagnostic sector. In addition to historical fundamental analyses, the complete report available to purchase compares Wilson Therapeutics with three other pharmaceutical manufacturers in Europe: Irlab Therapeutics Ab (2014 sales of 54,000.00 Swedish Kronor [US$6,724.08 ] ), Asit Biotech SA of Belgium (5,000.00 Euro [US$6,119.95 ] ), and Oasmia Pharmaceutical AB (60,000.00 Swedish Kronor [US$7,471.20 ] ).

Sales Analysis.
  Stock Performance Chart for Wilson Therapeutics
  Stock Data: Recent Stock Performance:
  Current Price (1/19/2018): 132.60
(Figures in Swedish Kronor)
1 Week 3.8%   13 Weeks 32.3%  
4 Weeks 32.6%   52 Weeks 124.7%  
Wilson Therapeutics Key Data:
  Ticker: WTX Country: Sweden
  Exchanges: STO Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Biological Products Exc. Diagnostic
  2014 Sales 91,000
(Year Ending Jan 2015).
Employees: 14
  Currency: Swedish Kronor Market Cap: 3,410,504,885
  Fiscal Yr Ends: December Shares Outstanding: 25,720,248
  Share Type: Aktie Closely Held Shares: 614,131
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.